Greiner bio-one looks back on a very successful financial year 2020

| Company - Back to overview

The COVID-19 pandemic dominated 2020, and Greiner Bio-One products played an important role.

Kremsmünster, May 2021 – With the rapid development of the VACUETTE® virus stabilization tube and an intense focus upon research and laboratory products of relevance to COVID-19, Greiner Bio-One is making a key contribution to the conquest of the pandemic. The careful management of production capacity and close cooperation with our customers constitute the basis for an extremely successful business picture.

Sign-up to our newsletter or request more information here
Say hello
Register now and you will receive our regular Greiner Bio-One News on current topics to stay up-to-date.

We redirected you to your country page. To go back to the previous page, please click the button.

Go back

You are not viewing your country page. To switch to your country, please click the button.

Switch